These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3303297)

  • 61. Ranitidine in the treatment of peptic ulcer.
    Makalinao AU; Zaño FM
    Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
    Agrawal NM; Dajani EZ
    J Assoc Acad Minor Phys; 1992; 3(4):142-8. PubMed ID: 1392409
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
    Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
    Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
    Hawkey CJ; Naesdal J; Wilson I; Långström G; Swannell AJ; Peacock RA; Yeomans ND
    Gut; 2002 Sep; 51(3):336-43. PubMed ID: 12171953
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis.
    Steen KS; Lems WF; Aertsen J; Bezemer D; Dijkmans BA
    Ann Rheum Dis; 2001 May; 60(5):443-7. PubMed ID: 11302864
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Carprofen and the therapy of gastroduodenal ulcerations by ranitidine.
    Czarnobilski Z; Bem S; Czarnobilski K; Konturek SJ
    Hepatogastroenterology; 1985 Feb; 32(1):20-3. PubMed ID: 3872836
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
    Lazzaroni M; Sainaghi M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S48-53. PubMed ID: 10379470
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.
    Kummer AF; Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger SA
    Gut; 1992 Feb; 33(2):175-8. PubMed ID: 1541412
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ranitidine maintenance treatment of non-steroidal anti-inflammatory drug-induced duodenal ulceration.
    Penston JG; Wormsley KG
    Aliment Pharmacol Ther; 1989 Oct; 3(5):499-503. PubMed ID: 2518863
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of ranitidine and sucralfate in the long-term treatment of duodenal ulcer.
    Masoero G; Rocchia F; Rossanino A; Marchetto M; Benitti V; De la Pierre M
    J Clin Gastroenterol; 1986 Dec; 8(6):624-7. PubMed ID: 3805657
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
    Karateev AE; Nasonova VA
    Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
    Arkkila PE; Seppälä K; Kosunen TU; Sipponen P; Mäkinen J; Rautelin H; Färkkilä M
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):93-101. PubMed ID: 15647648
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.
    Chan FK; Sung JJ; Chung SC; To KF; Yung MY; Leung VK; Lee YT; Chan CS; Li EK; Woo J
    Lancet; 1997 Oct; 350(9083):975-9. PubMed ID: 9329511
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract.
    Agrawal NM
    Br J Rheumatol; 1995 Apr; 34 Suppl 1():5-10. PubMed ID: 7780679
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Therapy for ulcers and erosions associated with nonsteroidal anti-inflammatory drugs.
    Freeman HJ
    Can J Gastroenterol; 1998; 12(8):537-9. PubMed ID: 10206732
    [No Abstract]   [Full Text] [Related]  

  • 78. A comparison of 4-week peptic ulcer healing rates following treatment with antacids and ranitidine.
    Bezuidenhout DJ; Perold JG; Adams G
    S Afr Med J; 1984 Jun; 65(25):1007-9. PubMed ID: 6328685
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Approaches to healing and prophylaxis of nonsteroidal anti-inflammatory drug-associated ulcers.
    Yeomans ND
    Am J Med; 2001 Jan; 110(1A):24S-28S. PubMed ID: 11165992
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism].
    Simon B; Bergdolt H; Dammann H; Müller P
    Z Gastroenterol; 1991 May; 29(5):217-21. PubMed ID: 1950028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.